Results 231 to 240 of about 1,306,169 (311)

Plasmepsins as Antimalarial Drug Targets—Then, Now, and the Future

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Malaria is a devastating disease caused by Plasmodium parasites. Plasmodium parasites express ten cathepsin D‐like aspartyl proteases, called plasmepsins (PMs). These PMs have diverse roles fulfill diverse functions throughout the parasite's lifecycle, though several exhibit functional redundancies. Among them, PMV, PMIV, and PMX are essential
Brad E. Sleebs
wiley   +1 more source

A Service Ecosystems Approach for Sustainable Volunteer Engagement: Developing Insights From COVID‐19 Disruptions

open access: yesNonprofit Management and Leadership, EarlyView.
ABSTRACT The purpose of this paper is to develop foundational propositions designed to reflect success factors in the recruitment and retention of volunteers for future longevity. Using insights gathered from three universities' experiences of student volunteering during COVID‐19, plus capturing the experiences of volunteer involving organizations, we ...
Ingrid O'Brien   +5 more
wiley   +1 more source

Effects of Interprofessional Collaborative Practice in Older Adults’ Hip Fractures Care: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

open access: yesResearch in Nursing &Health, EarlyView.
ABSTRACT This study aimed to evaluate the effectiveness of interprofessional collaborative practice interventions in improving activities of daily living, quality of life, length of stay, and in reducing mortality among older adults with hip fractures. Systematic review and meta‐analysis of randomized controlled trials.
Santo Imanuel Tonapa   +3 more
wiley   +1 more source

Experiences of Humanizing Care in Nursing Students-A Phenomenological Study. [PDF]

open access: yesHealthcare (Basel)
Dávila MFV   +3 more
europepmc   +1 more source

Hemophilia A: An Ideal Disease for Prenatal Therapy

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Hemophilia A (HA) is the most common inherited coagulation defect. Current state‐of‐the‐art treatment consists of frequent administration of prophylactic infusions of coagulation factor VIII (FVIII) protein or bispecific antibodies that replace the cofactor function of FVIIIa to maintain hemostasis. However, these treatments are far from ideal,
Christopher D. Porada   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy